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Abstract
Background: Pharmacologic control of Cre-mediated recombination using tamoxifen-dependent activation of a Cre-
estrogen receptor ligand binding domain fusion protein [CreER(T)] is widely used to modify and/or visualize cells in the
mouse.
Methods and Findings: We describe here two new mouse lines, constructed by gene targeting to the Rosa26 locus to
facilitate Cre-mediated cell modification. These lines should prove particularly useful in the context of sparse labeling
experiments. The R26rtTACreER line provides ubiquitous expression of CreER under transcriptional control by the
tetracycline reverse transactivator (rtTA); dual control by doxycycline and tamoxifen provides an extended dynamic range of
Cre-mediated recombination activity. The R26IAP line provides high efficiency Cre-mediated activation of human placental
alkaline phosphatase (hPLAP), complementing the widely used, but low efficiency, Z/AP line. By crossing with mouse lines
that direct cell-type specific CreER expression, the R26IAP line has been used to produce atlases of labeled cholinergic and
catecholaminergic neurons in the mouse brain. The R26IAP line has also been used to visualize the full morphologies of
retinal dopaminergic amacrine cells, among the largest neurons in the mammalian retina.
Conclusions: The two new mouse lines described here expand the repertoire of genetically engineered mice available for
controlled in vivo recombination and cell labeling using the Cre-lox system.
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Introduction
Altering the mouse genome by Cre-mediated recombination is
one of the central technologies of modern mammalian genetics
[1]. An important adjunct to this technology has been the
development of a method for pharmacologic control of Cre-
mediated recombination by fusing Cre with a mutant estrogen
receptor ligand-binding domain that recognizes 4-hydroxytamox-
ifen (4HT) rather than estrogen [CreER(T); referred to hereafter
as CreER; 2,3]. The CreER protein is sequestered in the cytosol
until 4HT exposure releases it for nuclear migration.
For typical applications of the CreER technology - for example,
experiments involving timed inactivation of conditional alleles -
highly efficient recombination is considered desirable. By contrast,
relatively inefficient recombination is essential for experiments in
which the goal is to monitor the behavior, morphology, or function
of individual genetically modified cells in an environment
populated by unmodified neighbors. In extreme cases - for
example, experiments using genetically encoded reporters to study
the morphologies of very large CNS neurons - the efficiency of
recombination must be lowered to fewer than 20 cells per mouse
[4]. Other applications have used sparse labeling with Cre/loxP
recombination to study neuronal morphologies in the retina [5], to
define the role of the Frizzled5 receptor in the survival of thalamic
neurons [6], and to compare the roles of transcription factors
Brn3a and Brn3b in retinal ganglion cell (RGC) development [7].
One limitation of the mouse lines currently available for sparse
labeling relates to the efficiency of Cre-mediated recombination,
which varies substantially with different combinations of CreER
source and loxP target. For example, we observed that the Z/AP
line, which expresses human placental alkaline phosphatase (AP)
upon excision of a loxP-flanked beta-geo/transcriptional stop
cassette [8], recombines with an efficiency ,1,000 lower than
similarly designed conditional AP knock-in alleles of the Brn3a and
Brn3b genes (Brn3a
CKOAP and Brn3b
CKOAP), when each target gene is
tested with a ubiquitously expressed CreER knock-in at the Rosa26
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7859locus (R26CreER; 7,9,10). In the absence of 4HT, R26CreER;Z/AP
mice typically exhibit no AP+ cells per retina, whereas
R26CreER;Brn3a
CKOAP/+ and R26CreER;Brn3b
CKOAP/+ mice exhibit
several hundred AP+ RGCs per retina. A similar differential in the
number of AP+ neurons is observed following in utero or early
postnatal exposure to 4HT, with a single IP injection of 100–
200 mg in the early postnatal period producing several dozen AP+
RGCs per R26CreER;Z/AP retina and many thousands of AP+
RGCs per R26CreER;Brn3a
CKOAP/+ or R26CreER;Brn3a
CKOAP/+
retina [7,10].
For sparse labeling of neurons without selection for a particular
subtype, the R26CreER;Z/AP combination with an early postnatal
injection of 4HT generates a frequency of labeling that is close to
optimal for morphologic analyses [(0.001%–0.01% of neurons
labeled; 5,10]. When the Z/AP reporter is used in conjunction
with a set of cell-type selective CreER lines – produced by knocking
an IRES-CreER into the 39 untranslated region (UTR) of the genes
coding for choline acetyl transferase (ChAT-IRES-CreER)o r
tyrosine hydroxylase (TH-IRES-CreER) - the low level of CreER
production, together with the relatively small number of
catecholaminergic or cholinergic neurons, results in extremely
sparse cell labeling [4].
In the present work we have enhanced the sparse labeling
technique by developing two Rosa26 knock-in mouse lines: one line
increases the dynamic range of CreER action, and the second line
exhibits Cre-mediated activation of AP with high efficiency and
with undetectable background AP activity in unrecombined cells.
The R26rtTACreER line uses the reverse tetracycline transactivator
(rtTA) and doxycycline to control the expression of CreER, with
the result that 4HT-induced Cre recombinase activity can be set at
a level that is substantially lower than that typically obtained with
constitutively expressed CreER lines. Thus the R26rtTACreER line
permits precisely timed sparse recombination of target loci with a
high efficiency of Cre-mediated recombination. Because the
Rosa26 locus is widely expressed, the R26rtTACreER line can be
used to generate sparse genetic mosaics to test the behavior of
individual mutant cells in a wide variety of tissues and/or in
situations in which the conventional null allele is lethal. The
R26IAP line complements the popular but inefficiently recombin-
ing Z/AP line by providing an AP reporter that exhibits high
efficiency Cre-mediated recombination in virtually any cell. The
R26IAP line should prove especially useful when paired with
CreER loci that exhibit low levels of 4HT-induced Cre activity.
We demonstrate the utility of the latter line by using it to: (a) assess
the efficiency of Cre-mediated recombination following either
direct uptake of Cre protein or infection by an adenovirus vector
expressing Cre, (b) generate brain atlases of sparsely labeled
cholinergic and catecholaminergic neurons, and (c) characterize
the morphologies of type 1 dopaminergic retinal amacrine cells,
which have axon-like arbors that are among the largest of any cells
in the mammalian retina.
Results
R26rtTACreER: Dual Control of Cre Action by Doxycycline
and 4-Hydroxytamoxifen (4HT)
To construct a ubiquitously expressed CreER(T) allele (hereafter
referred to as ‘CreER’; 2) with a large dynamic range of CreER
expression, we generated the Rosa26 knock-in allele R26rtTACreER
(Figure 1A,B). In this allele, CreER is under the control of the
reverse tetracycline trans-activator (rtTA), a sequence-specific
DNA-binding protein that activates transcription upon binding
tetracycline derivatives such as doxycycline [11]. The rtTA coding
sequences are transcribed as part of the ubiquitously expressed
Rosa26 transcription unit and are joined by splicing to the 59 exon
of this transcript. Upon administration of doxycycline (in food
pellets and/or drinking water), rtTA activates transcription of the
CreER coding region by binding to seven tandem copies of the
Tet operator located immediately 59 of a minimal promoter.
To systematically explore the relationship between the level and
t i m i n go fd o x y c y c l i n ea n d4 H Te x p o s u r ea n dt h ee f f i c i e n c yo fC r e -
mediated recombination, we analyzed the expression of AP in RGCs
using R26rtTACreER;Brn3a
CKOAP/+ and R26rtTACreER;Brn3b
CKOAP/+
mice (Figure 2; see Figure 1 of [reference 7] for a schematic of these
reporters). Doxycycline was delivered in food pellets at 1.75 mg/g
and/or in drinking water at 0.5, 1, or 2 mg/ml. 4HT dissolved in
vegetable oil was delivered to pregnant females or to early postnatal
mice as a single IP injection. Retina flat mounts were prepared from
adult mice, stained histochemically for AP activity, and scored as
Figure 1. Structures of the R26rtTACreER and R26IAP knock-in
alleles. (A) The WT Rosa26 locus showing the location of the
ubiquitous transcript derived from this locus and the unique Xba I
site into which the rtTACreER and IAP cassettes were inserted. (B) The
R26rtTACreER locus. The rtTA coding region is preceded by a splice
acceptor so that it can be spliced onto the 59 exon of the endogenous
Rosa26 transcript, and it is followed by multiple transcription
termination signals (‘‘stop’’). In the presence of doxycycline, the rtTA
protein activates transcription from the seven head-to-tail Tet response
elements immediately 59 of a minimal cytomegalovirus immediate early
promoter (‘‘TRE’’), leading to expression of the CreER coding region. The
resulting CreER protein translocates to the nucleus upon binding to 4-
hydroxytamoxifen (4HT). (C) The R26IAP locus in its germline
configuration (upper diagram) and following Cre-mediated recombina-
tion (lower diagram). The IAP region is preceded by a splice acceptor so
that it can be spliced onto the 59 exon of the endogenous Rosa26
transcript. In the germline configuration, the two loxP sites in head-to-
head orientation surround a central region that must be inverted to
generate a correctly configured human placental alkaline phosphatase
(hPLAP) minigene (lower diagram). In the orientation shown in the
lower diagram, one loxP site resides in the intron and the second loxP
site resides in the 39 UTR. For the R26rtTACreER allele, the frt-flanked
PGK-Neo selectable marker used during ES culture was removed by Flp-
mediated recombination in the mouse germline. Scale bars in A, B and
C are 1 Kb.
doi:10.1371/journal.pone.0007859.g001
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Figure 2E, F), sparse labeling (1–50 RGCs per retina; Figure 2C),
or no labeling (Figure 2B). Various dosing regimens were tested,
of which 33 are shown diagrammatically in Figure 2A. For each
of the two genotypes tested, the diagrams have been ordered with
respect to recombination efficiency, presented in the histograms
on the right side of Figure 2A.
From these experiments several patterns emerge. First, initiating
doxycycline exposure after approximately embryonic day (E) 5
gives low or no recombination, even if a large dose of 4HT is
Figure 2. Dose and timing of doxycycline and 4HT exposure on Cre-mediated recombination efficiency using R26rtTACreER. (A)
Individual experiments are numbered, the doxycycline and 4HT regimens are shown schematically, and the number of mice with high/medium,
sparse, or no AP+ labeling of RGCs is shown in the color-coded histograms at right. Experiments 1–21 and 22–33 were performed with
R26rtTACreER;Brn3a
CKOAP/+ and R26rtTACreER;Brn3b
CKOAP/+ mice, respectively. (B–F) Representative retina flat mounts (B,C,E,F) and a 200 mm coronal
brain section at the level of the superior colliculus (D) were obtained from the numbered experiments indicated in the lower right corner of each
panel. A single IP injection was used to deliver 4HT either to the mother for in utero exposure or to individual pups for postnatal exposure.
doi:10.1371/journal.pone.0007859.g002
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(Figure 2B). Second, continuous exposure to doxycycline begin-
ning prior to or at E0 produces recombination in a dose-
dependent manner, with some recombination seen even in the
absence of 4HT [e.g., experiments 13, 18–21, 28, 32, and 33];
(Figure 2F). Third, initiating doxycycline exposure between E2
and E4 and delivering 4HT between E10 and E12 gives dose-
dependent recombination that results in a relatively sparse
collection of AP+ RGCs suitable for the analysis of single cell
morphologies [e.g., experiments 2, 3, 11, 12, 24–27];
(Figure 2C,E). In particular, in experiments 2, 3, and 11 (with
the Brn3a
CKOAP/+ target), two experiments showed no labeled
neurons and one experiment showed sparse labeling in more than
half the retinas. Similarly, in experiments 24, 25, and 27 (with the
Brn3b
CKOAP/+ target), one third of the retinas have no labeled
neurons and two thirds of the retinas have a sparse distribution of
labeled neurons.
Interestingly, several retinas with sparse labeling exhibited
clusters of AP+ RGCs indicative of early clonal activation or
repression (e.g., Figure 2C); an analogous clustering of AP+
neurons and their processes were observed in the brains of several
of these mice, as seen in the coronal section through the superior
colliculus in Figure 2D. Importantly, clustering of labeled RGCs
was observed in retinas that received 4HT after E11, a time when
there are already many hundreds of retinal progenitors and lateral
migration of cells within a single retinal clone is severely restricted
[10]. Thus, the data suggest that the clonal restriction reflects
events that occurred earlier in development, such as epigenetic
silencing of rtTA expression and/or rtTA-dependent activation of
the CreER target in a subset of cells. It seems plausible to suppose
that the spatial patterns of clonal restriction might reflect the same
epigenetic process that silences CreER expression when doxycy-
cline is not delivered in early gestation. The weak AP staining of all
axon bundles in Figures 2B and C arises from a low-level
background of AP expression in RGCs from the Brn3a
CKOAP and
Brn3b
CKOAP alleles in the absence of Cre-mediated recombination.
In sum, by using an appropriate regimen of doxycycline
exposure, the R26rtTACreER locus can be used, even with highly
recombinogenic target loci, to generate a sparse set of labeled cells
at a developmental time point determined by 4HT injection.
R26IAP: A Sensitive Cre-Dependent AP Reporter for a
Broad Array of Tissues and Cell Types
To create an AP reporter that is activated by Cre-mediated
recombination with an efficiency higher than the relatively
inefficient Z/AP locus and to eliminate background AP activity
in unrecombined cells, a Rosa26 knock-in allele was constructed
with an AP coding region in which the 39 half is inverted (R26IAP;
Figure 1C). Upon Cre-mediated recombination, the 39 half of the
coding region, which is flanked by loxP sites in head-to-head
orientation, is flipped into the correct orientation in a subset of
cells. On the assumption that a variable number of DNA inversion
events occurs before dissociation of the Cre/loxP complex, we
expect that the recombination process would produce a mixture of
correct and inverted orientations in those cells in which
recombination has occurred. Therefore, AP expression from the
R26IAP allele should persist in a subset of recombined cells, with
virtually no background AP activity in unrecombined cells. Cre-
mediated inversion has been used previously in experiments in
which extremely tight control of gene expression was essential, for
example in the in vivo analysis of oncogenic fusion proteins [12].
As an initial test of the efficiency of Cre-mediated recombina-
tion at the R26IAP locus, we examined AP expression by
histochemical staining of adult tissues in R26CreER;R26IAP mice
that had not been exposed to 4HT (Figure 3A,B). This analysis
revealed 4HT-independent recombination at a frequency of
hundreds of cells per retina and ,1,000 cells per 300 mm
vibratome section of brain, roughly similar to the levels observed
with R26CreER;Brn3a
CKOAP/+ and R26CreER;Brn3b
CKOAP/+ mice in
the absence of 4HT. As noted in the Introduction, R26CreER;
Z/AP mice average ,1A P + cells per retina or 300 mm brain
section in the absence of 4HT [10]. In R26CreER;R26IAP mice,
the number of AP+ cells increased by several orders of magnitude
following a single IP injection of 200 mg 4HT at P3, resulting in
AP-stained retina flat mounts that are completely opaque (not
shown). Recombination in R26CreER;R26IAP mice is observed in a
wide variety of tissues, as expected for expression of both CreER
and AP from the Rosa26 locus. For example, Figure 3C and D
shows scattered AP+ cells in the lens and cornea following
intraocular delivery of 6 mg 4HT in adult mice.
Using R26IAP to Assess the Efficiency of Different
Methods for Cre Delivery
The relatively high recombination efficiency of the R26IAP
locus, together with the high sensitivity of AP histochemistry,
suggested that the R26IAP locus might be generally useful for
monitoring the efficiency of Cre-mediated recombination in a
variety of experimental contexts. To test this idea, we have used
R26IAP to compare Cre-mediated recombination following: (a)
direct uptake of purified Cre protein fused to a poly-basic peptide
(His-NLS-Cre; 13) injected into the peritoneal cavity or into the
eye (Figure 3E–H), or (b) infection with a defective adenovirus
vector expressing Cre (Ad-Cre) delivered by intravenous or
intraocular injection (Figure 3I–O). Each of these methods of
Cre administration induced recombination at the R26IAP locus,
with the cell type, location, and efficiency of recombination
reflecting the delivery route and vehicle.
Intraperitoneal (IP) injection of His-NLS-Cre in adulthood led
to recombination predominantly in epithelial cells lining the
peritoneal cavity, as seen on the surface of the liver, stomach, and
abdominal wall (Figure 3E–G); the only AP+ cells not lining the
surface epithelium were occasional AP+ abdominal wall muscle
fibers (Figure 3F). Similarly, intraocular (i.e. intravitreal) injection
of His-NLS-Cre at P5 induced recombination principally in retinal
cells in close proximity to the vitreal surface: RGCs, astrocytes,
and superficial vascular cells (Figure 3H). Intraocular injection of
Ad-Cre in adult mice resulted in transduction of Cre into retinal
and corneal cells (Figure 3I and J), and tail vein injection of Ad-
Cre in adult mice resulted in efficient recombination in the liver
(Figure 3O) and scattered recombination in the kidney, with the
highest efficiency in the renal pelvis (Figure 3K–N). Intraocular
injections of His-NLS-Cre or Ad-Cre gave highly variable
frequencies of recombination within the retina, ranging from few
or no recombination events to nearly confluent AP staining across
the retina, a variability that most likely reflects variation in needle
placement, volume injected, and the fraction of the injected
volume retained within the eye. In the absence of His-NLS-Cre
protein or Ad-Cre virus or a genetically introduced Cre or CreER
locus, no AP+ cells were observed in any tissues examined from
R26IAP mice, including brain, liver, stomach, kidney, eye, and
abdominal wall.
The Utility of Brain Atlases Composed of Sparsely
Labeled and Genetically Defined Neuronal Subtypes
The role of cholinergic and catecholaminergic (dopaminergic,
noradrenergic, and adrenergic) neurotransmission in brain
function and disease has been an object of long-standing scientific
New Cre/lox Genetic Tools
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catecholaminergic systems has been intensively studied in both
normal and diseased brains in a wide variety of species. In most
studies, cholinergic and catecholaminergic neurons have been
visualized by immunostaining for the biosynthetic enzymes choline
acetyl transferase (ChAT) and tyrosine hydroxylase (TH),
respectively, a method the reveals the cell bodies and processes
of all neurons of the particular neurotransmitter type. Due to the
high density and wide coverage of immunoreactive processes, this
approach generally reveals only minimal information about the
morphologies of individual neurons. In the present study, we have
developed a complementary method for visualizing systems of
neurons defined by neurotransmitter type. In this method, cell-
type specific, but relatively low frequency, Cre-mediated recom-
bination randomly labels a subset of neurons within the population
of interest to generate an atlas that reveals representative soma
locations, projections, and individual morphologies for all of the
neurons of that class.
Using ChAT-IRES-CreER;R26IAP Mice to Produce an Atlas
of Cholinergic Neurons
The application of this sampling method to the cholinergic
system is illustrated in Figure 4. In this experiment, a ChAT-IRES-
Figure 3. R26IAP is a sensitive reporter for Cre-mediated recombination in individual cells. (A–D) R26CreER;R26IAP mice either in the
absence (A,B) or following intra-ocular injection (C,D) of 4HT show widespread Cre-mediated recombination in diverse cell types. A, brain; B, retina, C,
lens, D, cornea. AP+ lens fiber and lens epithelial cells are seen in C. The overall frequency of AP-expressing cells in the brain and retina in the absence
of 4HT is ,0.01%. (E–G) R26IAP mice that received an IP injection of ,184 mg of purified His-NLS-Cre protein show scattered Cre-mediated
recombination only in epithelial cells lining the peritoneal cavity or in the muscle fibers of the abdominal wall immediately beneath the peritoneal
surface. E, liver; F, abdominal wall; G, stomach. (H) R26IAP mice that received an intraocular injection of ,7 mg of purified His-NLS-Cre protein at ,P5
show scattered Cre-mediated in RGCs and in occasional astrocytes. RGC axons are converging on the optic nerve head at the top of the panel. (I,J)
Retina (I) and cornea (J) following an intra-ocular injection of a replication defective adenovirus expressing Cre. Cre-mediated recombination andA P
expression are confined to tissues near the injection site. In the retina, the compact appearance of the AP+ cells and the absence of AP+ axons
suggests that most of the labeled cells are astrocytes and/or Muller glia. (K–O) Tissues from R26IAP mice in the absence (K) or following IV injection
(L–O) of a replication defective adenovirus expressing Cre (Ad-Cre). K–N, kidney; O, liver. The boxed region of the renal pelvis in L is enlarged in M. N
shows a region of renal cortex from a different mouse that received an IV injection of Ad-Cre in which Cre-mediated recombination was also observed
in a subset of cortical tubules. Scale bars are: 1 mm for E and O; and 200 mm for D,F,G,H,J,M, and N.
doi:10.1371/journal.pone.0007859.g003
New Cre/lox Genetic Tools
PLoS ONE | www.plosone.org 5 November 2009 | Volume 4 | Issue 11 | e7859CreER;R26IAP mouse was injected IP with 200 mg 4HT at P8, and
one month later a complete series of 300 mm coronal brain
sections was histochemically stained for AP (Figure 4N). The
distribution of AP+ cell bodies and processes was found to be in
excellent agreement with the distribution of cholinergic neurons
and processes observed in mouse and rat brains by ChAT
immunostaining [14,15]. In the following paragraph, we summa-
rize the distribution of the AP+ neurons and processes in the
ChAT-IRES-CreER;R26IAP brain, proceeding in a rostral to caudal
direction.
AP+ neurons with well-defined processes were observed in the
medial septum (Figure 4A,B) and in the basal forebrain in and
near the substantia innominata (Figure 4C,D). In the striatum,
AP+ neurons had both thick tortuous dendrites and a halo of
much finer (presumably axonal) processes (Figure 4A,C,E). A large
number of fine AP+ processes were found throughout the cortex
and hippocampus, as expected for diffuse cholinergic projections
originating in the basal forebrain (Figure 4F,G); an especially
dense plexus of AP+ processes was present in the basolateral
nucleus of the amygdala (Figure 4F-H). Near the pons/midbrain
junction, AP+ neurons were localized to the laterodorsal tegmental
nucleus and the pedunculopontine tegmental nucleus (Figure 4I,J).
In the caudal medulla, AP+ neurons were seen in the dorsal motor
nucleus of the tenth (vagus) nerve (Figure 4K,L). In retina flat
mounts, AP labeling was confined to starburst amacrine cells, the
only cholinergic cell type within the mammalian retina, confirm-
ing the specificity of ChAT-IRES-CreER expression (Figure 4M).
Using TH-IRES-CreER;R26IAP Mice to Produce an Atlas of
Catecholaminergic Neurons
To further extend the approach of labeling a subset of neurons
within a given neurotransmitter system, we have also generated an
atlas of labeled neurons for the catecholaminergic systems by
targeting R26IAP recombination with TH-IRES-CreER following
IP injection of 100 mg 4HT at P3. Figure 5 shows a series of
300 mm coronal sections from a TH-IRES-CreER;R26IAP brain
that was histochemically stained for AP (Figure 5N). The
distribution of AP+ cell bodies and processes was found to be in
excellent agreement with the distribution of catecholaminergic
Figure 4. Survey of cholinergic neuronal morphologies and projections in the brain and retina of R26IAP;ChAT-IRES-CreER mice.
Animals were injected with a single IP injection of 200 mg 4HT at P8. (A,C,F,I,K) 300 mm coronal sections at Bregma positions 1.2, 0, 22.5, 25.0, and
27.8, respectively, as shown schematically in (N). (B,D,E,G,H,J,L) enlargements of boxed regions. (M) In a flat mounted retina, AP-expression is present
exclusively in starburst amacrine cells. In the absence of 4HT, retinas were devoid of AP+ cells. BNA, basolateral nucleus of the amygdala; DMN(VN),
dorsal motor nucleus of the vagus nerve; LDTN, laterodorsal tegmental nucleus; MS, Medial septum; PPTN; pedunculopontine tegmental nucleus; SI,
substantia innominata; St, striatum.
doi:10.1371/journal.pone.0007859.g004
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immunostaining [16–21]. Below we summarize the distribution of
AP+ neurons and processes in the TH-IRES-CreER;R26IAP brain,
proceeding in a rostral to caudal direction.
In the TH-IRES-CreER;R26IAP forebrain, dense AP+ processes,
but very few AP+ cell bodies, were seen in the nucleus accumbens,
striatum, ventral pallidum, and the central nucleus of the
amygdala (Figure 5A–D), as expected for these principal targets
of innervation by midbrain dopaminergic and noradrenergic
neurons. At the level of the hypothalamus, scattered AP+ cell
bodies with a small number of thick processes were present in the
arcuate nucleus (Figure 5E and F). Intense AP staining was seen in
the median eminence, and AP+ neurons with numerous finer
processes were seen in the zona incerta (Figure 5E and F). The
greatest number of AP+ neuronal cell bodies were found in a
contiguous zone encompassing the substantia nigra pars reticulata
and the ventral tegmental area and extending caudally as far as the
pedunculopontine tegmental nucleus, nuclei that give rise to the
principal dopaminergic projections to the forebrain (Figure 5G–J).
At the junction of the midbrain and pons, large numbers of AP+
cells populate the dorsal raphe nucleus, a major source of
projections to the nucleus accumbens (Figure 5I). The locus
coeruleus, the site with the highest concentration of central
noradrenergic neurons, was densely populated with AP+ cells
(Figure 5K). Finally, AP+ neurons were observed in the caudal
medulla in the locations predicted for A1 and A2 noradrenergic
cell groups (Figure 5L and M).
Using TH-IRES-CreER;R26IAP Mice to Visualize the
Morphologies of Wide-Field Tyrosine Hydroxylase-
Expressing Amacrine Cells
As a further test of the utility of the R26IAP line, we have asked
whether we could use it to characterize the unusually large arbors
of dopaminergic amacrine (DA) cells in the mouse retina. DA cells
have been found in the retinas of a wide variety of vertebrates.
Both rodent and primate retinas have a distinctive type of TH+
amacrine cells (type 1 cells) characterized by large cell bodies with
two groups of neurites: one group forms a simple tree composed of
relatively thick dendrites, whereas the second is composed of
extremely long, thin, and sparsely branching axon-like processes
[22–24]. The dendritic and axon-like arbors are confined to the
outermost sublamina of the inner plexiform layer. In the primate
retina, the dendritic arbors of DA cells have diameters of
,400 mm near the fovea and ,600 mm in the periphery, whereas
the axon-like arbors encompass a diameter of at least 6 mm, the
exact value being difficult to ascertain due to uncertainty in the
extent of diffusion of the injected label [24]. Type 1 DA cells are
unusually sparse. In the primate retina they have a density of
,50/mm
2 near the fovea and about 10/mm
2 in the periphery,
and in the mouse and rabbit they have an average density of ,20/
mm
2, equivalent to ,450 and ,6,000 cells per retina, respectively
[24–27]. Despite their relatively small numbers, dopamine
released by DA cells plays a central role in modulating retinal
signaling in response to changes in ambient illumination or
circadian cues [28–32].
Figure 5. Survey of catecholaminergic neuronal morphologies and projections in the brain of TH-IRES-CreER;R26IAP mice. Animals
were injected with 100 mg 4HT at P3. (A–E,G,I,K,L) 300 mm coronal sections at Bregma positions 1.7, 1.1, 0, 21.6, 22.2, 23.2, 24.7, 25.5, 28.2,
respectively, as shown schematically in (N). (F,H,J,M) enlargements of boxed regions. A1, A1 noradrenergic cell group; A2, A2 noradrenergic cell
group; AcN, accumbens nucleus; AN, arcuate nucleus; CNA, central nucleus of the amygdala; DRN, dorsal raphe nucleus; LC, locus coeruleus; ME,
median eminence; PPTN, pedunculopontine tegmental nucleus; SN(PR), substantia nigra (pars reticulata); St, striatum; VP, ventral pallidum; VTA,
ventral tegmental area; ZI, zona incerta.
doi:10.1371/journal.pone.0007859.g005
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immunostaining can been used to identify DA cells, but the extensive
intermingling of TH+ processes from different cells precludes the
tracingofindividualimmunolabeledarbors.Asimilarchallengeexists
for transgenic approaches in which the TH promoter drives
expression of a histochemical or fluorescent reporter [27,33,34].
In the present study, we have used TH-IRES-CreER;R26IAP
mice injected with 100–300 mg 4HT between P3 and P8 to
produce, on average, fewer than one AP+ DA cell per retina. This
window of injection times was chosen to roughly match the initial
appearance of TH+ amacrine cells in the rodent retina [35–37].
Among 120 adult retinas histochemically stained for AP and
examined as flat mounts, a total of 147 AP+ cells were observed,
and all were amacrine cells. Twenty-five of the AP+ cells exhibited
morphologies indicative of type 1 DA cells: a large soma, a
relatively simple dendritic arbor, and an extremely large and
sparsely branching axon-like arbor, with both arbors confined to
the outermost lamina of the inner plexiform layer (Figure 6A–C).
This narrow lamination is in contrast to the diverse lamination
within the inner plexiform layer that is seen with other large
polyaxonal amacrine cells in primate and rodent retinas [5,38,39]
The distribution of AP+ type 1 DA cells among the 120 retinas
was consistent with a Poisson process: the number of retinas with
zero, one, two, or more than two type 1 DA cells was 97, 21, two,
and zero, respectively. Fourteen of the type 1 DA cells were traced
(Figure 6A and B): 12 from retinas with a single type 1 DA cell,
and two from one retina that had a pair of type 1 DA cells. In the
retina with two type 1 DA cells (Figure 6B and C), the extensive
overlap between the two axon-like arbors precludes an accurate
assignment of connectivity for some of the axon-like segments.
Among the collection of AP+ type 1 DA cells, the relative
uniformity of the AP staining intensity along each axon-like process
and the sharp termination of AP staining at the presumptive ends of
these processes implies that their full extent has been visualized
(Figure 6C). Ingeneral, the axon-like arborsencompassedregionsof
the retina both near to and far from the cell body. There were
multiple examples of axon-like processes that projected close to the
edge of the retina and then continued circumferentially along the
retinal margin, suggesting that in the context of a larger retina this
axon-like trajectory would have continued radially to greater
distances from the cell body (Figure 6A). Despite the apparent
absence of a fixed branching pattern, the length distributions for
both the dendritic and axon-like arbors were remarkably narrow,
with a mean+/2S.D. of 46,908+/24,175 mm for axon-like
processes and 2,532+/2253 for dendrites [Figure 7; these values
areuncorrected forthe,30%tissueshrinkage causedbyclearing in
benzylbenzoate:benzyl alcohol (BBBA)]. These observations imply
the existence of a biochemical control system that precisely
calibrates the total length (or mass) of these arbors.
In addition to the 25 type 1 DA cells described above, a variety
of other AP+ amacrine cell types were also found in this set of 120
retinas: 110 AII amacrine cells, four starburst amacrine cells, four
large field amacrine cells, two ‘‘waterfall’’ amacrine cells, and two
narrow field amacrine cells [see ref. 5 for examples of these
morphologies]. Among the large field amacrine cells, at least one
corresponds to the morphology described for type 2 DA cells
(Figure 6D). We ascribe the occasional labeling of non-DA cell
types to low level mis-expression of TH-IRES-CreER in these other
neurons or in neuronal progenitors.
Discussion
The two new mouse lines described here add to the growing list
of genetically engineered mice available for controlled in vivo
recombination and cell labeling using the Cre-lox system. The
R26rtTACreER line extends the dynamic range of Cre-mediated
recombination efficiencies relative to that of other loci with a
constitutively expressed CreER, and the R26IAP line complements
the widely used Z/AP line by providing substantially higher
efficiency Cre-mediated activation of AP. We note that Que and
colleagues [40] have recently described the construction of a
Rosa26 knock-in mouse line in which a hPLAP coding region is
transcribed from a CMV enhancer/beta-actin promoter after Cre-
mediated excision of a loxP-stop-loxP cassette.
It seems likely that for applications requiring low efficiency
recombination, the dynamic range and temporal control offered
by R26rtTACreER represents an improvement over pre-existing
lines in which the Tet system controls a constitutively active Cre
recombinase [41–44]. It will be interesting to extend the
rtTACreER strategy by targeting this cassette to loci that confer
cell-type specific expression. Based on our observations with the
R26rtTACreER locus, we would predict that this two-stage
pharmacologic strategy will also confer tighter control of Cre
activity relative to the standard CreER cassette at other sites in the
genome.
Factors Affecting the Efficiency of Cre-Mediated
Recombination
The roughly one thousand-fold difference between Z/AP and
R26IAP recombination frequencies emphasizes the large effect of
chromosomal location and/or target gene sequence on the
efficiency of Cre-mediated recombination. This effect is substan-
tially larger than the variation typically observed among target loci
[45]. A second variable that affects the efficiency of Cre-mediated
recombination is developmental age. With multiple target loci for
which the efficiency of Cre-medated recombination can be easily
quantified with AP histochemistry - including Brn3a, Brn3b, Z/AP,
and Fz5 - we have consistently observed a decline in efficiency
with increasing postnatal age when tested with a variety of CreER
lines, including R26CreER, NFL-IRES-CreER, and ChAT-IRES-
CreER (our unpublished observations). As the expression of the
Rosa26, NFL, and ChAT genes persists in adulthood, the observed
decline in recombination efficiency with age is unlikely to arise
from the loss of CreER expression. With the R26rtTACreER system
we observe an age dependent silencing that can be inhibited by
initiating doxycycline exposure – and presumably rtTA activated
transcription – in early embryonic development.
These age-dependent phenomena likely represent progressive
epigenetic changes in gene structure. A recent comparison of
recombination efficiencies among the Z/AP, Z/EG, and R26R-
EYFP loci in hematopoietic cells found a similar decline in
recombination efficiency with age, as well as a strong correlation
between lower recombination efficiency in adulthood and
increased cytosine methylation, suggesting that age-dependent
changes in chromatin structure can render loxP targets less
accessible to Cre recombinase [46]. Consistent with our
experience with the R26rtTACreER locus, studies of rtTA
activation of target genes reveals a progressive silencing in neurons
that can be overcome either by maintaining a basal level of target
gene expression throughout development or by providing very
high levels of rtTA [47].
In studies in which highly efficient Cre-mediated recombination
is desirable, the use of a constitutively active Cre-recombinase -
even in combination with an inefficient loxP target such as Z/AP -
usually suffices to produce complete or nearly complete recom-
bination [8]. When temporal control of recombination is also
required and the CreER system is used, obtaining highly efficient
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4HT administered over multiple days [3].
By contrast, for sparse cell labeling experiments, the challenge is
reversed: the problem is now to reduce the efficiency of 4HT-
dependent Cre-mediated recombination and eliminate any
background of 4HT-independent recombination. As shown in
Figure 3A and B, when using CreER alleles with relatively high
levels of expression (e.g. R26CreER) in combination with relatively
efficient loxP targets (e.g. R26IAP), background recombination is
substantial even in the absence of 4HT. Using a less efficient loxP
target, such as Z/AP, reduces the recombination level so that there
are few or no labeled cells in the absence of 4HT [10]. However,
in our experience, the Z/AP locus is unusual in this respect, and
most loxP target loci more closely resemble R26IAP in recombi-
nation efficiency. Long and Rossi [46] have suggested that the
unusually inefficient recombination efficiencies of the Z/AP and
Figure 6. Morphologies of individual AP+ type 1 DA cells from the retinas of TH-IRES-CreER;R26IAP mice. A single 100–300 mg 4HT
injection was administered IP between P3 and P8; retinas were analyzed ,6 weeks later. Retina flat mounts were processed for AP histochemistry and
clarified in BBBA. Axon-like processes (green) and dendrites (blue) were traced with Neuromantic software. The soma is indicated by a red arrow. The
outline of the flattened retina and the location of the optic disc are shown in red. (A) Twelve retinas, each of which had a single type 1 DA cell. (B) A
retina with two type 1 DA cells. (C) Image of the boxed region of the retina shown in (B). The dendrites (lower right) are uniformly thicker and more
darkly stained than the axon-like processes. (D) A putative type 2 DA cell. Scale bars in B and D, 500 mm. Scale bar in B applies to panels A and B. BBBA
causes ,30% tissue shrinkage.
doi:10.1371/journal.pone.0007859.g006
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region, which is present as part of the beta-geo coding region in
both loci and may promote somatic cytosine methylation and
epigenetic silencing.
A second strategy for reducing recombination efficiency focuses
on reducing CreER expression, either by using an IRES-CreER
knock-in allele, which likely decreases translation inefficiency, or,
as in the R26rtTACreER locus, by overlaying a second level of
transcriptional regulation. Both of these approaches for reducing
CreER can eliminate background recombination in the absence of
4HT. Finally, combining both an inefficient loxP target (Z/AP)
and low CreER expression reduces recombination to extremely
low levels, such that fewer than one hundred neurons can be
reproducibly labeled per brain depending on the IRES-CreER
knock-in and the time and dose of 4HT [4].
Sparse Labeling of Defined Neuronal Types as a Tool to
Survey Changes in CNS Structure
A method for visualizing the morphologies of a large and
representative sampling of neurons of a genetically defined type
has the potential to fill a hitherto vacant niche in neuro-anatomic
analyses of brain structure. Historically, the analysis of neuronal
morphology has been performed either by sparse labeling methods
that are not cell type specific (e.g. the Golgi stain) or by filling
individual neurons with a tracer using a whole cell patch electrode,
a method that is extremely laborious and not easily adaptable as a
survey tool [e.g. ref. 48]. These classic methods also suffer from the
problem of incomplete filling of large and/or complex neuronal
processes. At the other end of the spectrum with respect to the
number of labeled cells, immunostaining for markers such as
ChAT or TH reveals all of the cells of a given type, but the high
density of labeled cells and their interdigitating processes generally
preclude an assessment of individual morphologies. Moreover, the
immunostaining approach is limited to those antigens that are
relatively abundant, cytosolic, and cell-type specific. Thus, many
molecular markers that distinguish neuronal types, such as
transcription factors, or various low abundance or transiently
expressed proteins cannot be used directly to reveal the
morphologies of the cells in which they are [or were] expressed.
While this last challenge is being partially addressed by the
creation of BAC transgenic lines that express GFP or Cre in
defined subsets of cells [e.g. refs 49,50], the challenge of visualizing
individual neuronal morphologies can only be met by a method
that generates a relatively sparse collection of labeled neurons.
The strategy of generating a sparsely labeled sampling of a
single neuronal type – what we refer to here as an atlas of
morphologies - is illustrated here for cholinergic and catechol-
aminergic neurons. The method takes advantage of the flexibility
afforded by 4HT dosing to noninvasively generate a collection of
several dozen to several hundred labeled neurons throughout the
entire CNS. Current evidence suggests that the 1–2 month delay
between Cre-mediated recombination and histologic analysis
provides sufficient time for AP to uniformly populate the plasma
membrane of all dendritic and axonal processes even among the
largest neurons [4]. This approach could be used to survey the
survival and morphology of defined classes of neurons in mouse
models of a variety of CNS diseases or insults, including inherited
disease, stroke, infection, drug toxicity, and sensory deprivation.
For unilateral perturbations - such as a surgical lesion, localized
drug injection, or recombinant virus injection – labeled cells
ipsilateral and contralateral to the site of the manipulation can be
compared.
The Morphologies of Type 1 DA Cells in the Mouse Retina
DA cells, first defined as dopamine-accumulating neurons and
subsequently shown to express TH, have been extensively studied
in a variety of species [22–25,51]. Their wide arbors and diffuse
coverage likely reflect the role of dopamine as a neuromodulator
that acts on a broad and still incompletely enumerated group of
target cells to modulate retinal sensitivity. The best-characterized
effect of dopamine in the retina is in mediating the light-dependent
uncoupling of horizontal and amacrine cell gap junctions
[reviewed in ref. 28]. Recent work suggests that retinal dopamine
release is regulated by both ambient light level and by the
circadian clock [29–32].
To the best of our knowledge, the full morphology of individual
type 1 DA cells has not been previously reported in any species
owing to uncertainties regarding the completeness of tracer filling.
Dacey has estimated the diameter of the type 1 primate DA cell
axon-like arbor at ,8–10 mm based on a quantitative analysis of
arbor density, cell density, and the morphology of HRP filled cells
[24]. The cell morphologies determined here indicate that the
typical type 1 DA cell in the mouse retina has axon-like processes
that extend both radially and circumferentially, forming a sparse
arbor that generally encompasses a substantial fraction of the
retinal area and has a total length of ,6.5 cm in a retina with a
flat mounted diameter of ,5 mm (Figure 7; values corrected for
tissue shrinkage in BBA). If the arbors were artificially straightened
and directed radially, they would extend to a distance of at least
several millimeters from the cell body (Figure 6). On the
assumption that signals received by the dendrites of type 1 DA
cells are transmitted along the full length of their axon-like arbors,
then it would appear that activation of even a small number of
these cells would produce a signal with a relatively uniformly
spatial output across the retina, a property consistent with the
known neuromodulatory functions of retinal dopamine.
In relation to the cell biological mechanisms that control the
development of neuronal morphology, the large and irregularly
shaped axonal arbors of the type 1 DA cells would appear to rule
out any constraints on axonal trajectories based on homotypic
signaling, as observed for axonal and dendritic arbors in
Drosophila [52,53] and as postulated for a variety of cell types
in the mammalian retina [54]. However, an interesting observa-
tion regarding type 1 DA cells is the very narrow length
distributions of the dendrites and axon-like processes (Figure 7).
These distributions suggest that there is a stringent control
mechanism that regulates the total length of each class of neuritic
process, even among cell types in which the branching pattern and
coverage geometry is highly variable. The hypothesized control
mechanism could, for example, reflect a genetic program that
Figure 7. Quantification of axon-like processes and dendrite
lengths for type 1 DA cells. Red circles, lengths calculated from the
Neuromantic tracing of BBBA clarified retinas. BBBA causes ,30% tissue
shrinkage. Black circle and error bars, mean+/2S.D.
doi:10.1371/journal.pone.0007859.g007
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are limiting for process formation.
Methods
ES Cells and Mouse Husbandry
Knock-in constructs were designed with inserts at the Xba I site
at the Rosa26 locus as indicated in Figure 1A. ES cells were
electroporated and colonies were selected in G418 and screened
by Southern blot hybridization with the 59 flanking probe shown
in Figure 1A. Karyotypically normal ES cells were used for
blastocyst injection. Following germline transmission of the
targeted allele, the PGK-neo cassette of R26rtTACreER was excised
by crossing to mice expressing Flp in the germline. The
R26rtTACreER and R26IAP lines have been maintained as
homozygous stocks on a mixed Sv1296C57BL/6 background.
Both lines have been deposited at the Jackson Laboratories and
are freely available. Mice were handled and housed in accordance
with the Johns Hopkins University Animal Care and Use Protocols
and IACUC guidelines.
Genotyping
PCR primers for genotyping are as follows. R26IAP [sense
strand, located in the first exon of AP: GGCAACGAGGT-
CATCTCCGTGATGAA; antisense strand, located in the intron
in the inverted configuration: GGTTGCCTGGGTCTGAGC-
TAGTGCC; product size: 290 bp); R26rtTATetCreER [sense
strand: CCCTCGTGATCTGCAACTCCAGTC (=TB29); an-
tisense strand: TAGAATCGGTGGTAGGTGTC; product size:
700 bp]; WT [(i.e. the untargeted) Rosa26 locus [sense strand:
TB29, listed above; antisense strand: GGAGCGGGAGAAATG-
GATATG; product size: 500 bp]. PCR was performed with
Advantage 2 Polymerase (Clontech, La Jolla, CA) using 35 cycles
of 30 seconds denaturation at 94uC, 30 second annealing at 60uC,
and 1 minute elongation at 72uC.
His-NLS-Cre and Ad-Cre
An E. coli expression plasmid encoding His-NLS-Cre [13] was a
kind gift of Dr. H. Earl Ruley (Vanderbilt University). His-NLS-
Cre expressed in E coli was purified to .90% homogeneity by
nickel chelate affinity chromatography. The protein was eluted in
500 mM imidazole, and concentrated and desalted by ultrafiltra-
tion against PBS supplemented with 150 mM NaCl. For IP
injection of His-NLS-Cre, 100 ml of a 1.84 mg/ml stock was
injected per adult mouse; for intraocular injection 2 mlo fa
3.52 mg/ml stock was injected per eye at P5 using a 30 gauge
needle. For IV injection into the tail vein, 400 ml of an Ad-Cre
stock (3610
9 plaque forming units/ml; Virenz, Baltimore, MD)
was injected per adult mouse; for intraocular injection, 1.5 mlo f
the same virus stock was injected per eye at .P21 with a glass
micro-needle. Tissues were analyzed .14 days later for IP His-
NLS-Cre and IV Ad-Cre injections, and .10 days later for
intraocular injections.
Doxycycline and 4HT Delivery
Doxycycline (Sigma, St. Louis, MO) was mixed with drinking
water and/or delivered as premixed food pellets (Research Diets,
Inc., New Brunswick, NJ). For experiments with R26rtTACreER
mice, 4HT (98% pure) was dissolved in ethanol, mixed with
sunflower seed oil (Sigma, St. Louis, MO), centrifuged under
vacuum to remove the ethanol, and delivered as a single IP
injection. For experiments with R26IAP mice, the same protocol
was followed except that 70% purity 4HT (Sigma) was used for
some experiments. For R26IAP mice, IP injections of 4HT were
performed between P3 and P8 at a dose of 0.03–0.04 mg/g body
weight.
Tissue Processing
Tissue processing and AP staining were performed essentially as
described in ref. 10. For tissues other than eyes, mice were
anesthetized and subjected to transcardiac perfusion with 4%
paraformaldehyde in PBS. The brain, liver, or kidney was set in a
block of 3% low-melting point agarose in PBS and a series of
300 mm sections were cut with a vibratome. Segments of
abdominal wall and stomach were processed intact. Retinas were
dissected from eyes that had been immersion fixed in 4%
paraformaldehyde in PBS, and were gently flattened with a plastic
mesh. Tissues in PBS were heated in a water bath at 69uC for 90
minutes to inactivate endogenous AP and, for those embedded in
low melting point agarose, to melt the agarose surrounding the
tissue; heat-inactivated tissues were then reacted in NBT/BCIP for
several hours to overnight at room temperature with gentle
agitation. After washing and post-fixation, tissues were dehydrated
with a graded ethanol series, and clarified in 2:1 benzylbenzoa-
te:benzyl alcohol (BBBA). For long-term storage, samples were
returned to ethanol.
Microscopy and Neurite Tracing
Bright-field images were captured on a Zeiss dissecting
microscope equipped with OpenLab software, and bright-field
and DIC images were captured on a Zeiss Axio Imager Z1
microscope equipped with a motorized stage and AxioVision
software. For retina flat mounts, a montage of 5X images was
obtained with the Zeiss Axio Imager Z1 microscope using an X-Y
stage and the mosaics module and assembled using AxioVision
software. For type 1 DA cells, in which dendrites and axon-like
processes are confined to a single sublamina of the IPL, the AP-
labeled neurites were traced in the X–Y plane without loss of
information using Neuromantic software (www.rdg.ac.uk/neuro-
mantic/). For coronal brain sections, Bregma positions and
neuroanatomic structures were assigned as indicated in ref. 15.
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